Vaneck Biotech Etf Profile

BBH Etf  USD 174.89  0.74  0.42%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
VanEck Biotech is trading at 174.89 as of the 8th of November 2024. This is a 0.42 percent increase since the beginning of the trading day. The etf's open price was 174.15. VanEck Biotech has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for VanEck Biotech ETF are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 9th of October 2024 and ending today, the 8th of November 2024. Click here to learn more.
The fund normally invests at least 80 percent of its total assets in securities that comprise the funds benchmark index. Vaneck Biotech is traded on NASDAQ Exchange in the United States. More on VanEck Biotech ETF

Moving together with VanEck Etf

  0.83XLV Health Care SelectPairCorr
  0.84VHT Vanguard Health CarePairCorr
  0.82IBB iShares Biotechnology ETFPairCorr
  0.88IXJ iShares Global HealthcarePairCorr

Moving against VanEck Etf

  0.82MEME Roundhill InvestmentsPairCorr
  0.73RSPY Tuttle Capital ManagementPairCorr
  0.67DSJA DSJAPairCorr
  0.42CVX Chevron Corp Fiscal Year End 7th of February 2025 PairCorr
  0.41DIS Walt Disney Earnings Call This WeekPairCorr
  0.37JEPQ JPMorgan Nasdaq EquityPairCorr

VanEck Etf Highlights

Thematic Ideas
(View all Themes)
Old Names[Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG, Deutsche Balaton AG]
Business ConcentrationSector ETFs, Health Care ETFs, Health, VanEck (View all Sectors)
IssuerVan Eck
Inception Date2011-12-20
BenchmarkMarket Vectors US Listed Biotech 25 Index
Entity TypeRegulated Investment Company
Asset Under Management436.12 Million
Average Trading Valume3,215.6
Asset TypeEquity
CategorySector
FocusHealth Care
Market ConcentrationDeveloped Markets
RegionGlobal
AdministratorVan Eck Associates Corporation
AdvisorVan Eck Associates Corporation
CustodianState Street Bank and Trust Company
DistributorVan Eck Securities Corporation
Portfolio ManagerHao-Hung Peter Liao, Guo Hua Jason Jin
Transfer AgentState Street Bank and Trust Company
Fiscal Year End31-Oct
ExchangeNASDAQ
Number of Constituents26.0
Market MakerVirtu Financial
Total Expense0.35
Management Fee0.35
Country NameUSA
Returns Y T D4.5
NameVanEck Biotech ETF
Currency CodeUSD
Open FigiBBG000C1FW33
In Threey Volatility18.83
1y Volatility16.19
200 Day M A169.82
50 Day M A176.39
CodeBBH
Updated At8th of November 2024
Currency NameUS Dollar
VanEck Biotech ETF [BBH] is traded in USA and was established 2011-12-20. The fund is classified under Health category within VanEck family. The entity is thematically classified as Sector ETFs. VanEck Biotech ETF currently have 478.42 M in assets under management (AUM). , while the total return for the last 3 years was -3.0%.
Check VanEck Biotech Probability Of Bankruptcy

Geographic Allocation (%)

Top VanEck Biotech ETF Etf Constituents

BGNEBeiGeneStockHealth Care
ILMNIlluminaStockHealth Care
VRTXVertex PharmaceuticalsStockHealth Care
SGENSeagen IncStockHealth Care
REGNRegeneron PharmaceuticalsStockHealth Care
NVAXNovavaxStockHealth Care
MRNAModernaStockHealth Care
IQVIQVIA HoldingsStockHealth Care
More Details

VanEck Biotech ETF Risk Profiles

The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in VanEck Biotech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures.

VanEck Biotech Against Markets

When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
The market value of VanEck Biotech ETF is measured differently than its book value, which is the value of VanEck that is recorded on the company's balance sheet. Investors also form their own opinion of VanEck Biotech's value that differs from its market value or its book value, called intrinsic value, which is VanEck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VanEck Biotech's market value can be influenced by many factors that don't directly affect VanEck Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VanEck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if VanEck Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VanEck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.